← All Panbela Therapeutics, INC filings

Panbela Therapeutics, INC Form 4 insider transactions

Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.

OTC.Pink
PBLA
Panbela Therapeutics, INC
Form 4: Nant Capital Increases Stake in Panbela Therapeutics Through Convertible Note Purchase
Nant Capital, LLC, and its owner Patrick Soon-Shiong, have increased their stake in Panbela Therapeutics through the purchase of an 8% Senior Convertible Note, potentially converting into a significant portion of the company's common stock.
OTC.Pink
PBLA
Panbela Therapeutics, INC
Form 4: Panbela Therapeutics CFO Granted Stock Options
Susan Horvath, CFO of Panbela Therapeutics, received stock options for 25,480 shares on October 1, 2024.
OTC.Pink
PBLA
Panbela Therapeutics, INC
Form 4: Panbela Therapeutics CEO Acquires Stock Options
Jennifer K. Simpson, President and CEO of Panbela Therapeutics, Inc., acquired stock options on October 1, 2024.